| Trade Names: | |
| Synonyms: | |
| Status: | Approved (2008) |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| ATC: | C01EB21 |
| UNII: | 7AXV542LZ4 |
| InChI Key | LZPZPHGJDAGEJZ-AKAIJSEGSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C15H20N8O6 |
| Molecular Weight | 408.38 |
| AlogP | -2.43 |
| Hydrogen Bond Acceptor | 12.0 |
| Hydrogen Bond Donor | 5.0 |
| Number of Rotational Bond | 4.0 |
| Polar Surface Area | 186.46 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 3.0 |
| Heavy Atoms | 28.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| AGONIST | Adenosine A2a receptor agonist | DailyMed |
| Primary Target | |
|---|---|
| A2A receptor |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Membrane receptor
Family A G protein-coupled receptor
Small molecule receptor (family A GPCR)
Nucleotide-like receptor (family A GPCR)
Adenosine receptor
|
10000 | - | - | 290-1269 | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Coronary Disease | 3 | D003327 | ClinicalTrials |
| Retinal Artery Occlusion | 2 | D015356 | ClinicalTrials |
| Anemia, Sickle Cell | 2 | D000755 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 313348-27-5 |
| ChEBI | 135613 |
| ChEMBL | CHEMBL317052 |
| DrugBank | DB06213 |
| DrugCentral | 2362 |
| EPA CompTox | DTXSID4057712 |
| FDA SRS | 7AXV542LZ4 |
| Guide to Pharmacology | 5596 |
| KEGG | D05711 |
| PharmGKB | PA166129536 |
| PubChem | 44154280 |
| SureChEMBL | SCHEMBL678893 |
| ZINC | ZINC000013818943 |
| CAS NUMBER | 313348-27-5 |
| ChEMBL | CHEMBL3989695 |
| DrugBank | DB06213 |
| EPA CompTox | DTXSID70236374 |
| FDA SRS | 2XLN4Y044H |
| Guide to Pharmacology | 5596 |
| KEGG | D05711 |
| PubChem | 44154280 |
| SureChEMBL | SCHEMBL15862934 |
| ZINC | ZINC13818943 |